SEC filings · customer concentration

Who depends on Actavis

Actavis appears in 2 disclosed customer relationships between 2012 and 2019.

0major customers now
—of revenue from them
0listed suppliers depending on it
2012–2019years covered
Free

Get an email when Actavis's customer concentration changes

When a new annual report adds a 10% customer, drops one, or moves a share by 5 points or more, you get the change and the filing link. Up to 10 companies per address, no account, unsubscribe with one click.

Suppliers that depend on Actavis

Listed companies whose annual report names Actavis as a customer worth 10% or more of their revenue. If Actavis cuts orders or switches supplier, these are the companies that feel it.

Formerly disclosed

SupplierIts revenue from this companyChange vs prior yearHistoryLatest filing
Ironwood PharmaceuticalsIRWD62%last FY 2014FY 2012: 67%FY 2013: 13%FY 2014: 62%3 yearsFY 2014 · filed 18 Feb 2015
Amphastar PharmaceuticalsAMPH14%last FY 2016FY 2012: 35%FY 2013: 35%FY 2014: 30%FY 2015: 21%FY 2016: 14%5 yearsFY 2016 · filed 15 Mar 2019

About this data

US-listed companies must disclose revenue from any single customer that reaches 10% of their total (ASC 280). ShadowGraph reads these disclosures from the XBRL data of every 10-K and 20-F we scan, keeps one value per fiscal year (restatements replace earlier values) and links each number to its filing. Companies that describe a customer only as "Customer A" are not listed by name. Figures are as reported; nothing here is investment advice.

All companies · Latest dependency shifts · Bulk data and API